Rapid membrane affinity concentration assays

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5206136
SERIAL NO

07925311

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Rapid assays for analytes of interest in a fluid sample utilize a first conjugate of a labelled reactant that specifically binds to the analyte, and a second conjugate that binds to the analyte coupled to a polymer that has an affinity for a selected solid phase. The reaction components are incubated briefly, then contacted with the selected solid phase and the labelled components determined. Optional wash steps provide for enhanced sensitivity and specificity. When the analyte of interest is an antibody to HIV, the first reactant may be a synthetic, recombinant or native HIV antigen, and the second reactant may be protein A or an anti-immunoglobulin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENETIC SYSTEMS CORPORATIONREDMOND WASHINGTON 98052

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cole, Carol-Ann Seattle, WA 5 22
Monji, Nobuo Seattle, WA 12 185

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation